Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Gastrointestinal dysfunctions"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review Article
Gastrointestinal Autonomic Dysfunction in Patients with Parkinson’s Disease
Joong-Seok Kim, Hye-Young Sung
J Mov Disord. 2015;8(2):76-82.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15008
  • 41,391 View
  • 266 Download
  • 42 Web of Science
  • 44 Crossref
AbstractAbstract PDF
Currently, gastrointestinal dysfunctions in Parkinson’s disease (PD) are well-recognized problems and are known to be an initial symptom in the pathological process that eventually results in PD. Gastrointestinal symptoms may result from the involvement of either the central or enteric nervous systems, or these symptoms may be side effects of antiparkinsonian medications. Weight loss, excessive salivation, dysphagia, nausea/gastroparesis, constipation, and defecation dysfunction all may occur. Increased identification and early detection of these symptoms can result in a significant improvement in the quality of life for PD patients.

Citations

Citations to this article as recorded by  
  • Regulation of Pain Perception by Microbiota in Parkinson Disease
    Zulmary Manjarres, Margarita Calvo, Rodrigo Pacheco, Habibeh Khoshbouei
    Pharmacological Reviews.2024; 76(1): 7.     CrossRef
  • Emerging wearable technologies for multisystem monitoring and treatment of Parkinson’s disease: a narrative review
    Yasmine M. Kehnemouyi, Todd P. Coleman, Peter A. Tass
    Frontiers in Network Physiology.2024;[Epub]     CrossRef
  • N-acetyl-L-leucine protects MPTP-treated Parkinson’s disease mouse models by suppressing Desulfobacterota via the gut-brain axis
    Zhifeng Xu, Changlin Lian, Lixin Pan, Wenjie Lai, Fen Zhang, Lingmei Peng, Sijie Zhou, Guanghua Zhao, Xuezhu Yang, Guohua Zhang, Zefeng Tan, Yukai Wang
    Brain Research Bulletin.2023; 202: 110729.     CrossRef
  • Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
    Alyssa Chiew, David Mathew, Chandra M. Kumar, Edwin Seet, Farnad Imani, Seyed-Hossein Khademi
    Anesthesiology and Pain Medicine.2023;[Epub]     CrossRef
  • Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
    Nirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, Atul P. Sherje, Manisha Jignesh Oza, Gaurav Mahesh Doshi
    CNS & Neurological Disorders - Drug Targets.2023; 22(7): 1008.     CrossRef
  • A look back at the prodromal findings in Parkinson’s disease
    Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
    Bulletin of the National Research Centre.2023;[Epub]     CrossRef
  • Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
    Xuxiang Zhang, Beisha Tang, Jifeng Guo
    Translational Neurodegeneration.2023;[Epub]     CrossRef
  • Association between malnutrition and motor/non-motor symptoms in elderly with Parkinson disease
    Heewon Bae, Sang-Won Ha
    Journal of Geriatric Neurology.2023; 2(2): 58.     CrossRef
  • Gastrointestinal Sensory Neuropathy and Dysmotility in Fabry Disease: Presentations and Effect on Patient's Quality of Life
    Nir Bar, Amel Karaa, Katheryn Kiser, Braden Kuo, Claire Zar-Kessler
    Clinical and Translational Gastroenterology.2023; 14(12): e00633.     CrossRef
  • Nutritional aspects in Parkinson’s disease
    Paulina Gątarek, Joanna Kałużna-Czaplińska
    Critical Reviews in Food Science and Nutrition.2022; 62(23): 6467.     CrossRef
  • Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
    Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo
    Nutrients.2022; 14(2): 380.     CrossRef
  • Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait
    Li-Li Zhang, Liang Zhang, Jingde Dong, Ying Zhao, Xiao-Ping Wang
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
    Tong Guo, Li Chen
    European Journal of Inflammation.2022; 20: 1721727X2210837.     CrossRef
  • Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
    Sujith Pavan, Arvind N. Prabhu, Sankar Prasad Gorthi, Bhabatosh Das, Ankur Mutreja, Vignesh Shetty, Thandavarayan Ramamurthy, Mamatha Ballal
    Folia Microbiologica.2022; 67(5): 693.     CrossRef
  • Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
    Parvin Oroojzadeh, Saber Yari Bostanabad, Hajie Lotfi
    Journal of Molecular Neuroscience.2022; 72(9): 1952.     CrossRef
  • Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease
    Jinyoung Youn, George Umemoto, Eungseok Oh, Jinse Park, Wooyoung Jang, Yoon-Sang Oh, Hee-Tae Kim, Jin Whan Cho, Shinsuke Fujioka, Yoshio Tsuboi
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
    Yasir Bashir, Asad U. Khan
    Frontiers in Neuroscience.2022;[Epub]     CrossRef
  • Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
    Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun
    Microbial Pathogenesis.2021; 150: 104675.     CrossRef
  • Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis
    Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang
    Acta Pharmaceutica Sinica B.2021;[Epub]     CrossRef
  • Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens
    Christopher Kapitza, Rittika Chunder, Anja Scheller, Katherine S. Given, Wendy B. Macklin, Michael Enders, Stefanie Kuerten, Winfried L. Neuhuber, Jürgen Wörl
    International Journal of Molecular Sciences.2021; 22(6): 3233.     CrossRef
  • Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein
    Zhe Zhong, Weijie Chen, Huan Gao, Ningning Che, Min Xu, Lanqing Yang, Yingfang Zhang, Min Ye
    Neurochemical Research.2021; 46(11): 3050.     CrossRef
  • ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
    Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness
    Journal of Parkinson's Disease.2021; 11(4): 1821.     CrossRef
  • The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
    Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
    Pharmacological Research.2021; 172: 105840.     CrossRef
  • Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice
    Namkwon Kim, Seung Ho Jeon, In Gyoung Ju, Min Sung Gee, Jimin Do, Myung Sook Oh, Jong Kil Lee
    Brain, Behavior, and Immunity.2021; 98: 357.     CrossRef
  • Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
    Sachin Kumar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harassi, Mohammed M. Abdel-Daim, Simona Bungau
    Neurotoxicity Research.2021; 39(6): 2141.     CrossRef
  • Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
    Zhe Zhao, Jingwen Ning, Xiu-qi Bao, Meiyu Shang, Jingwei Ma, Gen Li, Dan Zhang
    Microbiome.2021;[Epub]     CrossRef
  • Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson’s disease
    Shanti Diwakarla, David I. Finkelstein, Remy Constable, Olivia Artaiz, Madeleine Di Natale, Rachel M. McQuade, Enie Lei, Xin‐yi Chai, Mitchell T. Ringuet, Linda J. Fothergill, Victoria A. Lawson, Laura J. Ellett, Joel P. Berger, John B. Furness
    Neurogastroenterology & Motility.2020;[Epub]     CrossRef
  • Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
    Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Pa
    European Journal of Pharmaceutical Sciences.2020; 147: 105280.     CrossRef
  • Estado nutricional de idosos com doença de Parkinson e seus fatores associados: uma revisão integrativa
    Nívola Beatriz Mendonça de Arruda, Suelane Renata de Andrade Silva, Nadja Maria Jorge Asano, Maria das Graças Wanderley de Sales Coriolano
    Revista Brasileira de Geriatria e Gerontologia.2020;[Epub]     CrossRef
  • Probiotics for Parkinson’s Disease
    Gazerani
    International Journal of Molecular Sciences.2019; 20(17): 4121.     CrossRef
  • Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease
    Eliseu da Cruz Moreira-Junior
    Medical Hypotheses.2019; 133: 109399.     CrossRef
  • Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease
    Yongtao Zhou, Yusheng Su, Weihua Xu, Wei Wang, Shukun Yao
    Current Neurovascular Research.2019; 16(3): 241.     CrossRef
  • α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon
    M. Swaminathan, C. Fung, D.I. Finkelstein, J.C. Bornstein, J.P.P. Foong
    Neuroscience.2019; 423: 76.     CrossRef
  • Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
    Meng-Fei Sun, Ying-Li Zhu, Zhi-Lan Zhou, Xue-Bing Jia, Yi-Da Xu, Qin Yang, Chun Cui, Yan-Qin Shen
    Brain, Behavior, and Immunity.2018; 70: 48.     CrossRef
  • Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
    Meng-Fei Sun, Yan-Qin Shen
    Ageing Research Reviews.2018; 45: 53.     CrossRef
  • Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK
    Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden
    British Journal of Clinical Pharmacology.2018; 84(11): 2551.     CrossRef
  • Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial
    Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Ab
    Clinical Neuropharmacology.2018; 41(5): 151.     CrossRef
  • Role of Microbiota in Neurodegenerative Diseases
    C. V. Sobol
    Russian Journal of Developmental Biology.2018; 49(6): 297.     CrossRef
  • α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
    Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
    Neurological Sciences.2017; 38(1): 171.     CrossRef
  • Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
    Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
    Journal of Movement Disorders.2017; 10(1): 29.     CrossRef
  • Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
    Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little, Han Joon Kim
    Expert Review of Neurotherapeutics.2017; 17(7): 737.     CrossRef
  • Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota
    Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu
    Brain Research.2016; 1642: 180.     CrossRef
  • Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study
    Chava Peretz, Ron Gurel, Violet Rozani, Tanya Gurevich, Baruch El-Ad, Judith Tsamir, Nir Giladi
    Parkinsonism & Related Disorders.2016;[Epub]     CrossRef
  • An Incidental Finding of a Radiopaque Pill following Cervical Spinal Surgery in a Parkinson's Disease Patient
    Bon Sub Gu, Soo-Jung Choi, Byoungwoo Yoo, Koon Hee Han, Jong Kyu Park, Young-Seok Lee, Jin Hoon Park
    Korean Journal of Spine.2015; 12(3): 153.     CrossRef

JMD : Journal of Movement Disorders